Abstract

Versatile Synthetic Substrates For Cellular Assay Development and 3D Organoid Culture and Screening

Connie Lebakken, Chief Operating Officer, Stem Pharm, Inc.

Stem Pharm Inc. has developed a synthetic hydrogel platform that allows the design and optimization of substrates for cell expansion, differentiation and screening applications including 3D cell culture and organoid models. Through control of the substrate mechanical properties and adhesion ligand presentation, and utilizing chemistries that maintain cellular health and function, we provide cell-specific biomaterials for advanced cellular assay platforms and specialized cell expansion and differentiation applications.